Loading…
This event has ended. Visit the official site or create your own event on Sched.
View analytic
Saturday, April 28 • 11:20am - 12:00pm
New Advances in the Impact of Anti-Inflammatory Treatment on Cardiovascular Risk

Sign up or log in to save this to your schedule and see who's attending!

Feedback form is now closed.
The role of chronic inflammation in the pathology and progression of immune-mediated diseases of the skin, joints, and bowel is well-established. However, there is an emerging appreciation for the role of chronic inflammation in cardiovascular disease as a major driver of atherosclerosis and other cardiovascular events. Thus, many of the immune- targeted biologics that have begun to revolutionize the management of skin, joint, and bowel diseases may have a therapeutic role in cardiovascular disease as well.

In this lecture, learn about the areas of overlap and intersection between chronic inflammation and cardiovascular disease, and the implications of this relationship on treatment. 

Speakers
avatar for Joel M. Gelfand, MD, MSCE

Joel M. Gelfand, MD, MSCE

Professor, Dermatology and Epidemiology; Vice Chair, Clinical Research; Director, Psoriasis and Phototherapy Treatment Center, University of Pennsylvania Perelman School of Medicine
Joel M. Gelfand is Professor of Dermatology and of Epidemiology (tenured); Vice Chair of Clinical Research (Dermatology), Senior Scholar, Center for Clinical Epidemiology and Biostatistics; Associate Fellow, Center for Public Health Initiatives; Medical Director of the Clinical S... Read More →


Saturday April 28, 2018 11:20am - 12:00pm
TBA